Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q2 EPS of ($0.69), $0.04 better than the analyst estimate of ($0.73).

For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.